Another Monster Biotech Deal: BMS Acquires Celgene for $74B
What a deal (https://news.bms.com/press-release/corporatefinan…).
Interesting that CVP aren't financial advisors for either side...
Thoughts?
What a deal (https://news.bms.com/press-release/corporatefinan…).
Interesting that CVP aren't financial advisors for either side...
Thoughts?
| +91 | [2026 - October] Unbiased Prestige Rankings | 53 | 1h |
| +87 | Who is the final boss in Houston Energy? (GS, JEFF or EVR) | 19 | 17h |
| +74 | You should probably leave IB | 26 | 1d |
| +45 | Why Do We Turn Comments? | 10 | 1d |
| +43 | Tomorrow Will Be Better | 5 | 4d |
| +41 | Moelis PCA vs Lower tier BB Coverage | 30 | 21h |
| +25 | Banking (Un)fortunately Still Needs You: My Case for Bankers in the AI Era | 3 | 1d |
| +24 | How much should you ask questions / seek feedback as an intern? | 9 | 2h |
| +23 | Lateraling as Analyst | 21 | 24m |
| +23 | UBS IB #24 in US M&A in 2026 | 10 | 18m |
Career Resources
Et id qui expedita est ad. Nemo occaecati est quia deserunt minima libero quas.
Aut voluptates consequatur quae. Alias neque voluptas doloribus illo. Hic possimus nemo nam impedit laboriosam facere. Voluptas aut culpa libero maiores ut consequatur. Vel alias ut repudiandae molestiae voluptas voluptatem debitis.
Ea aut ipsa adipisci dolor culpa vel pariatur totam. Repudiandae ex molestiae dolor nemo sit quia.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...